Starling Oncology, Inc.

STLNW
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001799191

Other share classesDFPHSTLN

Price chart

Open-market purchases and sales by STLNW insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 24, 20265:11 PM ETAug 21, 2026Hively BradDirectorSSaleCommon Stock−298.85K$6.5126−$1.95M411.98K−42.0%SEC10b5-1
Aug 17, 202610:13 AM ETAug 14, 2026Chernett Jorey10% OwnerPPurchaseCommon Stock+12K$6.54+$78.48K10.66M+0.1%SEC
Aug 17, 202610:13 AM ETAug 13, 2026Chernett Jorey10% OwnerSSaleCommon Stock · Derivative−10K$0.0624−$6240–SEC
Jul 22, 20269:55 AM ETJul 21, 2026Chernett Jorey10% OwnerPPurchaseCommon Stock+18K$5.27+$94.86K10.65M+0.2%SEC
Jul 16, 20268:05 PM ETJul 14, 2026Podnos YaleChief Medical OfficerSSaleCommon Stock−23.45K$6.4105−$150.34K259.53K−8.3%SEC10b5-1

The largest institutional positions in STLNW at the end of Q2 2026.

Institutions holding STLNW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Oasis Management Co Ltd.100,000$543K0.06%00.0%Unchanged
LMR Partners LLP1,624,856$66.29K0.00%00.0%Unchanged
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,250,000$51K0.00%00.0%Unchanged
WOLVERINE ASSET MANAGEMENT LLC418,214$17.06K0.00%+232,777+125.5%Added
Davidson Kempner Capital Management LP318,710$13K0.00%00.0%Unchanged